Differentiation of substrate and nonsubstrate inhibitors of the high- affinity, sodium-dependent glutamate transporters

Molecular Pharmacology

Volumn 56, Issue 6, 1999, Pages 1095-1104

  Koch, Hans P ^a   Kavanaugh, Michael P ^b   Esslinger, Christopher S ^a   Zerangue, Noah ^b   Humphrey, John M ^c   Amara, Susan G ^b,d   Chamberlin, A Richard ^c   Bridges, Richard J ^a  

^a UNIVERSITY OF MONTANA   (United States)

^b OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

^d HOWARD HUGHES MEDICAL INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMATE RECEPTOR;

ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CENTRAL NERVOUS SYSTEM; COMPETITIVE INHIBITION; CONFORMATIONAL TRANSITION; ENZYME SUBSTRATE; EXTRACELLULAR SPACE; GLIA CELL; MOLECULAR CLONING; NEUROTRANSMITTER RELEASE; NONHUMAN; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY; SYNAPTIC TRANSMISSION; SYNAPTOSOME;

EID: 0032732281     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.56.6.1095     Document Type: Article

References (43)

1. Arriza JL, Eliasof S, Kavanaugh MP and Amara SG (1997) Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci USA 94:4155-4160.
2. Arriza JL, Fairman WA, Wadiche JI, Murdoch GH, Kavanaugh MP and Amara SG (1994) Functional comparisons of three glutamate transporter subtypes cloned from human motor cortex. J Neurosci 14:5559-5569.
3. Arunlakshana O and Schild HO (1959) Some qualitative uses of drug antagonists. Br J Pharmacol 14:48-58.
4. Arzberger T, Krampfl K, Leimgruber S and Weindl A (1997) Changes of NMDA receptor subunit (NR1, NR2B) and glutamate transporter (GLT1) mRNA expression in Huntington's disease - an in situ hybridization study. J Neuropath Exp Neurol 56:440-454.
5. Booth RFG and Clark JB (1978) A rapid method for the preparation of relatively pure metabolically competent synaptosomes from rat brain. Biochem J 176:365-370.
6. Bridges RJ, Lovering FE, Humphrey JM, Stanley MS, Blakely TN, Christofaro MF and Chamberlin AR (1993) Conformationally restricted inhibitors of the high affinity L-glutamate transporter. Bioorg Med Chem Lett 3:115-121.
7. Bridges RJ, Levering FE, Koch H, Cotman CW and Chamberlin AR (1994) A Conformationally constrained competitive inhibitor of the sodium-dependent glutamate transporter in forebrain synaptosomes: L-anti-endo-3,4-Methanopyrrolidine dicarboxylate. Neurosci Lett 174:193-197.
8. Bridges RJ, Stanley MS, Anderson MW, Cotman CW and Chamberlin AR (1991) Conformationally defined neurotransmitter analogues. Selective inhibition of glutamate uptake by one pyrrolidine-2,4-dicarboxylate diastereomer. J Med Chem 34:717-725.
9. Chamberlin AR, Koch HP and Bridges RJ (1998) Design and synthesis of conformationally constrained inhibitors of high-affinity, sodium-dependent glutamate transporters. Methods Enzymol 296:175-189.
10. Choi DW (1994) Glutamate receptors and the induction of excitotoxic neuronal death. Prog Brain Res 100:47-51.
11. Choi DW (1995) Calcium: Still center-stage in hypoxic-ischemic neuronal death. Trends Neurol Sci 18:58-60.
12. Cotman CW, Kahle JS, Miller SE, Ulas J and Bridges RJ (1995) Excitatory amino acid neurotransmission, in Psychopharmacology: The Fourth Generation of Progress (Bloom FE and Kupfer DJ eds) pp 75-85, Raven Press, New York.
13. +-dependent glutamate transport activity in synaptosomes, C6 glioma, and Xenopus oocytes expressing excitatory amino acid carrier 1 (EAAC1). Mol Pharmacol 49:465-473.
14. Esslinger CS, Koch HP, Kavanaugh MP, Philips DP, Chamberlin AR, Thompson CM and Bridges RJ (1998) Structural determinants of substrates and inhibitors: Probing glutamate transporters with 2,4-methanopyrrolidine-2,4-dicarboxylate. Bioorg Med Chem Lett 8:3101-3106.
15. Fairman WA, Vandenberg RJ, Arriza JL, Kavanaugh MP and Amara SG (1995) An excitatory amino-acid transporter with properties of a ligand-gated chloride channel. Nature (Lond) 375:599-603.
16. f values in a variety of solvent systems. Anal Chem 35:389-398.
17. Gegelashvili G and Schousboe A (1997) High affinity glutamate transporters: Regulation of expression and activity. Mol Pharmacol 52:6-15.
18. Gegelashvili G and Schousboe A (1998) Cellular distribution and kinetic properties of high-affinity glutamate transporters. Brain Res Bull 45:233-238.
19. Griffiths R, Dunlop J, Gorman A, Senior J and Grieve A (1994) L-trans-Pyrrolidine-2,4-dicarboxylate and cis-1-aminocyclobutane-1,3-dicarboxylate behave as transportable, competitive inhibitors of the high-affinity glutamate transporters. Biochem Pharmacol 47:267-274.
20. Henn FA, Anderson DJ and Rustad DG (1976) Glial contamination of synaptosomal fractions. Brain Res 101:341-344.
21. Humphrey JM, Bridges RJ, Hart JA and Chamberlin AR (1994) 2,3-Pyrrolidinedi-carboxylates as neurotransmitter conformer mimics: Enantioselective synthesis via chelation-controlled enolate alkylation. J Org Chem 59:2467-2472.
22. Johnston GAR, Kennedy SME and Twitchin B (1979) Action of the neurotoxin kainic acid on high affinity uptake of L-glutamic acid in rat brain slices. J Neurochem 32:121-127.
23. Kanai Y and Hediger MA (1992) Primary structure and functional characterization of a high-affinity glutamate transporter. Nature (Lond) 360:467-471.
24. Kuhar MJ and Zarbin MA (1978) Synaptosomal transport: A chloride dependence for choline, GABA, glycine and several other compounds. J Neurochem 31:251-256.
25. Leigh PN and Meldrum BS (1996) Excitotoxicity in ALS. Neurol 47 (Suppl 4):S221-S227.
26. +-dependent glutamate uptake. J Neurosci 8:9620-9628.
27. Nakamura Y, Iga K, Shibata T, Shudo M and Kataoka K (1993) Glial plasmalemmal vesicles: A subcellular fraction from rat hippocampal homogenate distinct from synaptosomes. Glia 9:48-56.
28. Olney JW, Wozniak DF and Farber NB (1997) Excitotoxic degeneration in Alzheimer's disease: New hypothesis and new therapeutic strategies. Arch Neurol 54: 1234-1240.
29. Pines G, Danbolt NC, Bjoras M, Zhang Y, Bendahan A, Eide L, Koepsell H, Storm-Mathisen J, Seeberg E and Kanner BI (1992) Cloning and expression of a rat brain L-glutamate transporter. Nature (Lond) 360:464-467.
30. Robinson MB and Dowd LA (1997) Heterogeneity and functional properties of sub-types of sodium-dependent glutamate transporters in the mammalian central nervous system. Adv Pharmacol 37:69-115.
31. Rothman SM and Olney JW (1995) Excitotoxicity and the NMDA receptor - still lethal after eight years. Trends Neurol Sci 18:57-58.
32. Shimamoto K, LeBrun B, Yasuda-Kamatani Y, Sakaitani M, Shigeri Y, Yumoto N and Nakajima T (1998) D,L-threo-β-benzyloxyaspartate, a potent blocker of excitatory amino acid transporters. Mol Pharmacol 53:195-201.
33. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BJ and Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
34. +-independent glutamate/aspartate transporter from rat brain. Proc Natl Acad Sci USA 89:10955-10959.
35. Takahashi M, Billups B, Rossi D, Sarantis M, Hamann M and Attwell D (1997) The role of glutamate transporters in glutamate Homeostasis in the brain. J Exp Biol 200:401-409.
36. Tanaka K, Watase K, Manabe T, Yamada K, Watanabe M, Takahashi K, Iwama H, Nishikawa T, Ichihara N, Kikuchi T, Okuyama S, Kawashima N, Hori S, Takimoto M and Wada K (1997) Epilepsy and exacerbation of brain injury in mice lacking the glutamate transporter GLT-1. Science (Wash DC) 276:1699-1702.
37. Vandenberg RJ (1998) Molecular pharmacology and physiology of glutamate transporters in the central nervous system. Clin Exp Pharmacol Physiol 25:393-400.
38. Vandenberg RJ, Mitrovic AD, Chebib M, Balcar VJ and Johnston GAR (1997) Contrasting modes of action of methylglutamate derivatives on the excitatory amino acid transporters, EAAT1 and EAAT2. Mol Pharmacol 51:809-815.
39. Volterra A, Bezzi P, Rizzini BL, Trotti D, Ullensvang K, Danbolt NC and Racagni G (1996) The competitive transport inhibitor L-trans-pyrrolidine-2,4-dicarboxylate triggers excitotoxicity in rat cortical neuron-astrocyte co-cultures via glutamate release rather than uptake inhibition. Eur J Neurosci 8:2019-2028.
40. Wadiche JI and Kavanaugh MP (1998) Macroscopic and microscopic properties of a cloned glutamate transporter/chloride channel. J Neurosci 18:7650-7661
41. Willis CL, Dauenhauer D, Humphrey JM, Chamberlin AR, Buller A, Monaghan DT and Bridges RJ (1997) Methylation of the NMDA receptor agonist L-trans-2,3-pyrrolidine-dicarboxylate: Enhanced excitotoxic potency and selectivity. Toxicol Appl Pharmacol 144:45-55.
42. Yamashita H, Kawakami H, Zhang Y, Hagiwara T, Tanaka K and Nakamura S (1995) Inhibition by folded isomers of L-2-(carboxycyclopropyl)glycine of glutamate uptake via the human glutamate transporter hGluT-1. Eur J Pharmacol 289:387-390.
43. Zerangue N and Kavanaugh MP (1996) Flux coupling in a neuronal glutamate transporter. Nature (Lond) 383:634-637.